These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 31149644)

  • 1. Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma.
    Mukherjee P; Augur ZM; Li M; Hill C; Greenwood B; Domin MA; Kondakci G; Narain NR; Kiebish MA; Bronson RT; Arismendi-Morillo G; Chinopoulos C; Seyfried TN
    Commun Biol; 2019; 2():200. PubMed ID: 31149644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic therapy: a new paradigm for managing malignant brain cancer.
    Seyfried TN; Flores R; Poff AM; D'Agostino DP; Mukherjee P
    Cancer Lett; 2015 Jan; 356(2 Pt A):289-300. PubMed ID: 25069036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?
    Seyfried TN; Shelton L; Arismendi-Morillo G; Kalamian M; Elsakka A; Maroon J; Mukherjee P
    Neurochem Res; 2019 Oct; 44(10):2392-2404. PubMed ID: 31025151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model.
    Shelton LM; Huysentruyt LC; Seyfried TN
    Int J Cancer; 2010 Nov; 127(10):2478-85. PubMed ID: 20473919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nontoxic Targeting of Energy Metabolism in Preclinical VM-M3 Experimental Glioblastoma.
    Augur ZM; Doyle CM; Li M; Mukherjee P; Seyfried TN
    Front Nutr; 2018; 5():91. PubMed ID: 30349820
    [No Abstract]   [Full Text] [Related]  

  • 6. Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma.
    Rais R; Jančařík A; Tenora L; Nedelcovych M; Alt J; Englert J; Rojas C; Le A; Elgogary A; Tan J; Monincová L; Pate K; Adams R; Ferraris D; Powell J; Majer P; Slusher BS
    J Med Chem; 2016 Sep; 59(18):8621-33. PubMed ID: 27560860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of glucose and ketone bodies in the metabolic control of experimental brain cancer.
    Seyfried TN; Sanderson TM; El-Abbadi MM; McGowan R; Mukherjee P
    Br J Cancer; 2003 Oct; 89(7):1375-82. PubMed ID: 14520474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calorie restriction as an anti-invasive therapy for malignant brain cancer in the VM mouse.
    Shelton LM; Huysentruyt LC; Mukherjee P; Seyfried TN
    ASN Neuro; 2010 Jul; 2(3):e00038. PubMed ID: 20664705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-asparaginase and 6-diazo-5-oxo-L-norleucine synergistically inhibit the growth of glioblastoma cells.
    Ohba S; Hirose Y
    J Neurooncol; 2020 Feb; 146(3):469-475. PubMed ID: 32020477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [2,4-(13)C]β-hydroxybutyrate metabolism in astrocytes and C6 glioblastoma cells.
    Eloqayli H; Melø TM; Haukvik A; Sonnewald U
    Neurochem Res; 2011 Aug; 36(8):1566-73. PubMed ID: 21538079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the restricted ketogenic diet a viable alternative to the standard of care for managing malignant brain cancer?
    Seyfried TN; Marsh J; Shelton LM; Huysentruyt LC; Mukherjee P
    Epilepsy Res; 2012 Jul; 100(3):310-26. PubMed ID: 21885251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic management of microenvironment acidity in glioblastoma.
    Seyfried TN; Arismendi-Morillo G; Zuccoli G; Lee DC; Duraj T; Elsakka AM; Maroon JC; Mukherjee P; Ta L; Shelton L; D'Agostino D; Kiebish M; Chinopoulos C
    Front Oncol; 2022; 12():968351. PubMed ID: 36059707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic changes and anti-tumor effects of a ketogenic diet combined with anti-angiogenic therapy in a glioblastoma mouse model.
    Maeyama M; Tanaka K; Nishihara M; Irino Y; Shinohara M; Nagashima H; Tanaka H; Nakamizo S; Hashiguchi M; Fujita Y; Kohta M; Kohmura E; Sasayama T
    Sci Rep; 2021 Jan; 11(1):79. PubMed ID: 33420169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity.
    Oizel K; Chauvin C; Oliver L; Gratas C; Geraldo F; Jarry U; Scotet E; Rabe M; Alves-Guerra MC; Teusan R; Gautier F; Loussouarn D; Compan V; Martinou JC; Vallette FM; Pecqueur C
    Clin Cancer Res; 2017 Oct; 23(20):6292-6304. PubMed ID: 28720668
    [No Abstract]   [Full Text] [Related]  

  • 15. Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma.
    Tardito S; Oudin A; Ahmed SU; Fack F; Keunen O; Zheng L; Miletic H; Sakariassen PØ; Weinstock A; Wagner A; Lindsay SL; Hock AK; Barnett SC; Ruppin E; Mørkve SH; Lund-Johansen M; Chalmers AJ; Bjerkvig R; Niclou SP; Gottlieb E
    Nat Cell Biol; 2015 Dec; 17(12):1556-68. PubMed ID: 26595383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic resurgence of 6-diazo-5-oxo-l-norleucine (DON) through tissue-targeted prodrugs.
    Novotná K; Tenora L; Slusher BS; Rais R
    Adv Pharmacol; 2024; 100():157-180. PubMed ID: 39034051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy.
    Maurer GD; Brucker DP; Bähr O; Harter PN; Hattingen E; Walenta S; Mueller-Klieser W; Steinbach JP; Rieger J
    BMC Cancer; 2011 Jul; 11():315. PubMed ID: 21791085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-Norleucine.
    Wang SZ; Poore B; Alt J; Price A; Allen SJ; Hanaford AR; Kaur H; Orr BA; Slusher BS; Eberhart CG; Raabe EH; Rubens JA
    Clin Cancer Res; 2019 Oct; 25(19):5925-5936. PubMed ID: 31300448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting energy metabolism in brain cancer with calorically restricted ketogenic diets.
    Seyfried TN; Kiebish M; Mukherjee P; Marsh J
    Epilepsia; 2008 Nov; 49 Suppl 8():114-6. PubMed ID: 19049606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ketogenic diet and ketone monoester supplement on acute alcohol withdrawal symptoms in male mice.
    Bornebusch AB; Mason GF; Tonetto S; Damsgaard J; Gjedde A; Fink-Jensen A; Thomsen M
    Psychopharmacology (Berl); 2021 Mar; 238(3):833-844. PubMed ID: 33410985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.